Position in TVTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$87,221,584
+$36,128,674 QoQ
Shares Held
1,535,321
-10.7% QoQ
Ownership
1.63%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 315 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 0%
Common Shares in TVTX Over Time
Shares Held
Position Value (USD)
Derivatives in TVTX
reported options exposure · as of Mar 31, 2025CallValue
$3,852,800
CallShares
215,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. TVTX ranks #42 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in TVTX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,221,584 | 1,535,321 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $51,092,910 | 1,719,721 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $71,384,380 | 1,868,212 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $30,446,281 | 1,273,903 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $23,041,409 | 1,556,852 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,852,800 | 215,000 | Call | Defined | 2025-06-27 | |
| 2025-03-31 | $15,548,144 | 867,642 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $16,218,228 | 931,012 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $9,829,457 | 702,606 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,400,494 | 778,649 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,542,463 | 718,867 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $13,401,823 | 1,490,748 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $13,518,056 | 1,512,087 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $14,190,965 | 923,891 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $17,794,717 | 791,228 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $55,522,270 | 2,640,146 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $62,929,918 | 2,553,974 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $63,304,412 | 2,612,646 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $66,747,056 | 2,590,107 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $80,510,216 | 2,593,757 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $26,513,057 | 1,093,322 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $35,851,714 | 2,457,280 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $20,661,026 | 827,434 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $19,459,142 | 713,966 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 RTRX | — | 665,075 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 RTRX | — | 852,849 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 RTRX | — | 703,490 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||